Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases
Conditions: Primary Immune Deficiency Disorders; Hemophagocytic Lymphohistiocytosis; Inherited Bone Marrow Failure Syndrome; Hemoglobinopathies; Metabolic DisordersIntervention: Biological: BPX-501 and AP1903Sponsor: Bellicum PharmaceuticalsNot yet recruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Marrow Failure Syndrome (BMFS) | Cancer & Oncology | Genetics | Research | Stem Cell Therapy | Stem Cells | Study | Transplants